عمليات بحث ذات صلة

Position: Principal Software Engineer (Medical Imaging) Location: Doha, Qatar Job Id: 662 # of Openings: 1 Akura Medical, a Shifamed portfolio company, is advancing a differentiated platform for the treatment of venous thromboembolism (VTE). Akura recently received U.S. IDE approval for its QUADRA-PE study evaluating the Katana™ Thrombectomy System in...

Position: Staff Software Engineer (Medical Imaging) Location: Doha, Qatar Job Id: 661 # of Openings: 1 Akura Medical, a Shifamed portfolio company, is advancing a differentiated platform for the treatment of venous thromboembolism (VTE), which affects up to 900,000 Americans each year. The company recently received US IDE approval for its QUADRA-PE study...

Position: Staff Software Engineer (Medical Imaging) Location: Doha, Qatar Job Id: 661 # of Openings: 1 Akura Medical, a Shifamed portfolio company, is advancing a differentiated platform for the treatment of venous thromboembolism (VTE), which affects up to 900,000 Americans each year. The company recently received US IDE approval for its QUADRA-PE study...

The Opportunity A highly innovative, AI-native financial technology business is undertaking a confidential search for a Chief Technology Officer to lead its global technology and artificial intelligence agenda. The organisation operates at the intersection of AI, financial markets, data science and private-market investment intelligence, developing...

Position:Staff Software Engineer (Imaging) Location:Doha, Qatar Job Id:663 # of Openings:1 Company Overview Akura Medical, a Shifamed portfolio company, is advancing a differentiated platform for the treatment of venous thromboembolism (VTE), which affects up to 900,000 Americans each year. The company recently received US IDE approval for its QUADRA-PE...

Position: Principal Software Engineer (Medical Imaging) Location: Doha, Qatar Job Id: 662 # of Openings: 1 Akura Medical, a Shifamed portfolio company, is advancing a differentiated platform for the treatment of venous thromboembolism (VTE). Akura recently received U.S. IDE approval for its QUADRA-PE study evaluating the Katana™ Thrombectomy System in...